Compare MMT & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MMT | TKNO |
|---|---|---|
| Founded | 1987 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.2M | 236.6M |
| IPO Year | N/A | 2021 |
| Metric | MMT | TKNO |
|---|---|---|
| Price | $4.68 | $3.96 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 86.5K | ★ 128.5K |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | ★ 8.58% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | N/A | ★ $39,801,000.00 |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | N/A | $10.52 |
| P/E Ratio | $15.33 | ★ N/A |
| Revenue Growth | N/A | ★ 9.50 |
| 52 Week Low | $4.04 | $3.85 |
| 52 Week High | $4.70 | $10.37 |
| Indicator | MMT | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 48.89 | 29.96 |
| Support Level | $4.63 | $3.85 |
| Resistance Level | $4.69 | $4.86 |
| Average True Range (ATR) | 0.04 | 0.29 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 45.00 | 9.58 |
MFS Multimarket Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests a majority of its net assets in fixed-income securities, corporate bonds of the U.S and foreign issuers, U.S Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S and foreign issuers, and debt instruments of issuers located in emerging market countries. The portfolio of investments comprises of different sector investments such as aerospace, airlines, automotive, chemicals, electronics, and others.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.